Skip to main content
Caplight Logo









Videm

Videm

Private
GothenburgHealthcare & Life Scienceshttps://videm.com/

Last Round

Grant

Nov 10, 2023

Total Funding Raised

$625,000

Company Overview

Videm is a biotechnology company that develops point-of-care diagnostic technology for the simultaneous detection of nucleic acids and proteins.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

point-of-care diagnosticsPOC testingmolecular diagnosticsbiomarker detectionmultiplexed assayisothermal amplificationbiosensingnanotechnologydiagnostic devicemedical hardwarerapid testingclinical diagnosticslab-on-a-chip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Videm Comparables

Compare Videm with similar companies based on industry and business-model similarity.

Videm comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Proxim Diagnostics Corp.
82%
Aptitude Medical
79%
GRIP Molecular Technologies
79%

Videm Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 10, 2023
SeedMar 7, 2022

Key People

Founding team and executive leadership

Petter Barreng

Co-founder & CTO

Founding Team

Maria Barklund

Co-founder & CEO

Founding Team

Videm Investors

Notable investors and investment history

Videm investors
InvestorRounds
EQT FoundationSeed
Vasa Angels ISeed
VinnovaGrant
E14 InvestSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 24, 2026

    Grew 50% QoQ from 6 to 9 employees.

  • Jan 24, 2025

    Grew 50% QoQ, from 8 to 12 employees.

Videm Filings

Explore SEC and related filing metadata, where available.

Videm filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Videm's valuation, stock price, and market status.

Is Videm a public or private company?

Videm is a private company.

What is the current stock price of Videm?

Videm is a private company with no public stock price. Caplight tracks Videm's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Videm worth (valuation)?

Valuation information for Videm is not publicly available.

Can I buy Videm stock?

Videm shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Videm's last funding round?

Videm's most recent funding round was Grant on November 10, 2023.

Who are the main investors in Videm?

Key investors in Videm include EQT Foundation, Vasa Angels I, Vinnova, E14 Invest.

Will Videm IPO soon?

No public IPO plans have been announced for Videm.

How can I track Videm secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Videm's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGothenburg
Employee Range7
Year Founded2021
Last FundingNov 10, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?